THEBUSINESSBYTES BUREAU

NEW DELHI, NOVEMBER 21, 2026

India is aiming to build a USD 300-billion bioeconomy by 2030 and expand it to USD 1 trillion by 2047, Union Minister Jitendra Singh has said, stressing the need to accelerate research commercialisation, strengthen industry partnerships and attract global scientific talent to achieve the ambitious targets.

India's bioeconomy has grown from around USD 10 billion to more than USD 195 billion, reflecting the expanding contribution of biotechnology, innovation and technology to the country's economic growth, Singh said while chairing the fourth Annual General Meeting of the Biotechnology Research and Innovation Council (BRIC) Society here.

Describing BRIC as a pioneering model of institutional integration in the government, the minister said bringing biotechnology research institutions under a common umbrella was among the first initiatives of its kind and had subsequently inspired similar approaches in other organisations.

The initiative was conceived to promote shared infrastructure, collaborative research and integrated governance while allowing constituent institutions to retain their individual scientific strengths, he said.

Singh emphasised that scientific achievements should not remain confined to research publications and patents but must translate into technologies, products and solutions that address societal needs and improve people's lives.

Highlighting BRIC's research credentials, he said the council had ranked first among government institutions in health sciences and second in biological sciences in India for the second consecutive year, according to the Nature Index India.

BRIC institutions are undertaking research in healthcare, agriculture, animal health, advanced materials and technology platforms, including novel therapeutics, diagnostics, disease detection, climate-resilient agriculture and sustainable biomaterials.

The minister called for closer alignment of research priorities with national requirements, saying scientific innovation must deliver tangible benefits to patients, farmers, industries and communities.

Underlining the importance of taking research from laboratories to the marketplace, Singh said scientists, entrepreneurs, investors and industry must engage with one another from the early stages of technology development.

Research commercialisation requires capital, mentorship, industry partnerships and a better understanding of market and regulatory pathways, he said, adding that technology translation should become an integral part of the research ecosystem.

He welcomed initiatives such as the Entrepreneur-in-Residence programme and collaborations to strengthen biomanufacturing, technology scale-up and commercialisation, and urged BRIC institutions to build deeper links with industry and innovation networks.

India's biotechnology startup ecosystem, which now comprises more than 11,000 startups, reflects growing confidence in the country's scientific and entrepreneurial capabilities, Singh said.

He encouraged young scientists and innovators to move beyond publications and patents towards product development, technology translation and enterprise creation.

During the meeting, members also highlighted emerging opportunities at the intersection of artificial intelligence and biology, technology development and the need to attract Indian scientific talent working abroad to contribute to the country's research ecosystem.

Suggestions included leveraging platforms such as Vaibhav Connect to connect the scientific diaspora with research opportunities in BRIC institutions, promoting interdisciplinary engagement with social sciences and expanding partnerships with entrepreneurs and industry.

Referring to the D.E.S.I.G.N. for BioE3 Challenge, Singh said it had received more than 6,000 proposals from school students and citizens across its two categories, reflecting growing interest in biotechnology innovation.

He called for continued efforts to nurture young talent, attract promising researchers and create opportunities for ambitious interdisciplinary research, while making scientific achievements more accessible to the wider public.

The AGM also reviewed BRIC's institutional progress, scientific achievements, governance reforms, research collaborations and future priorities. Department of Biotechnology Secretary and BRIC Director General Rajesh S Gokhale presented a detailed account of the council's activities and achievements.

Singh welcomed the operationalisation of BRIC's Secretariat and efforts to strengthen research capacity through recruitment against revived scientific positions.

The meeting also witnessed the launch of the BRIC Handbook of Memorandum of Association, Rules, Regulations and Bye-laws, providing a consolidated reference for the council's governance and functioning.

Members were also apprised of the proposal to dissolve existing societies of constituent autonomous institutions and merge them with BRIC as part of the ongoing institutional restructuring.

Singh said BRIC's collaborative research model, shared infrastructure and interdisciplinary programmes would play an important role in strengthening India's biotechnology ecosystem and positioning the country as a global hub for scientific innovation.

The AGM was held at Kartavya Bhawan under the chairmanship of Singh, who holds the portfolios of Science and Technology and Earth Sciences as Minister of State (Independent Charge), besides being Minister of State in the Prime Minister's Office and other departments, and President of the BRIC Society.